SCHEMBL6474487

SCHEMBL6474487

COc1cc(-c2ccc(Cl)cc2)ccc1COCCc1cccc(NS(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.39
PPARG P37231 1/20 0.39
ERAP1 Q9NZ08 1/20 0.38
KDM1A O60341 1/20 0.38
CYP3A4 P08684 4/20 0.36
CYP2D6 P10635 3/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A3 Q01959 3/20 0.36
KCNH2 Q12809 1/20 0.36
CA2 P00918 1/20 0.35
MAPT P10636 1/20 0.34
PGR P06401 1/20 0.34
FABP4 P15090 1/20 0.34
PRMT6 Q96LA8 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480341 0.93 PPARA (0.39) PPARAPPARGERAP1KDM1ACYP3A4
SCHEMBL6475686 0.89 PPARA (0.41) PPARAPPARGKDM1ACYP3A4CYP2D6
SCHEMBL6483863 0.85 PPARA (0.47) PPARAPPARGKDM1ACYP3A4CYP2D6
SCHEMBL6473722 0.85 ADRB1 (0.39) PPARAPPARGERAP1KDM1ACYP3A4
SCHEMBL6474331 0.84 ERAP1 (0.38) ERAP1KDM1ACA2FABP4PRMT6
SCHEMBL6482076 0.83 KDM1A (0.38) ERAP1KDM1ACA2PRMT6PTGS1
SCHEMBL6482194 0.81 KDM1A (0.43) PPARAPPARGKDM1ACA2PRMT6
SCHEMBL6474945 0.80 KDM1A (0.39) PPARAPPARGKDM1ACYP3A4CYP2D6
SCHEMBL6481112 0.80 KDM1A (0.41) KDM1ACA2PRMT6PTGS1PTGS2
SCHEMBL6474334 0.80 CYP3A4 (0.40) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6930131-B2 Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM) WYETH (US) 2005-08-16 US claimed
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus WYETH (US) 2003-10-30 US claimed
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus WYETH (US) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203941-A1 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus GPR119, INSR, SLC5A1 PPARA 291/4885PPARG 256/4885ERAP1 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.